AMBRX BIOPHARMA INC-ADREquity-NMS: AMAM
Equity-NMS: AMAM
$28
NA
(6 Dec)
Loading Chart
1D
1W
3M
1Y
5Y
Previous close
$28.00
Open
$28.00
1Y
132.21%
Market cap
0
Insights
No insights found for this stock
Compare with other stock
Price
1D
PE
Market cap
About AMBRX BIOPHARMA INC-ADR

Ambrx Biopharma Inc. is a clinical-stage biologics company, which is focused on discovering and developing a class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids (SAA) that do not exist in nature into proteins within living cells.

Its product candidates are designed to overcome the inherent limitations of conventional conjugation approaches that use natural amino acids for non-site-specific conjugation. Its SAA incorporation technology allows to develop a wide array of product candidate modalities, such as antibody-drug conjugates (ADCs), bispecific antibodies, PEGylated peptides, modified cytokines and immuno-stimulating antibody conjugates (ISACs). Its lead ADC candidate is ARX788, an anti-HER2 ADC, being investigated in multiple clinical trials for the treatment of breast cancer, gastric/gastroesophageal junction (GEJ) cancer and other solid tumors. .


FAQs

Can I buy AMBRX BIOPHARMA INC-ADR shares in India?
How to buy AMBRX BIOPHARMA INC-ADR shares in India?
What is the share price of AMBRX BIOPHARMA INC-ADR?
What is the Market Capitalization of AMBRX BIOPHARMA INC-ADR?
What is the PE ratio of AMBRX BIOPHARMA INC-ADR?
Is AMBRX BIOPHARMA INC-ADR a good stock to buy?
In which sector / industry does AMBRX BIOPHARMA INC-ADR operate?